baCta Company Profile

Background

Overview

baCta, founded in 2024 and headquartered in Paris, France, is a biotechnology startup specializing in AI-driven bioproduction of industrial ingredients. The company leverages advanced synthetic biology to produce sustainable, carbon-negative natural rubber and other industrial ingredients using engineered microorganisms and renewable feedstocks. This innovative approach aims to revolutionize traditional manufacturing processes by offering eco-friendly alternatives to conventional methods.

Mission and Vision

baCta's mission is to unlock sustainable abundance of valuable molecules, starting with natural rubber. The company envisions a future where the majority of industrial ingredients are produced through biotechnological processes, paving the way for a more sustainable and abundant supply chain.

Industry Significance

The natural rubber industry, valued at approximately $40 billion, faces challenges such as deforestation and climate change impacts on rubber tree cultivation. baCta's innovative bioproduction methods present a significant opportunity to address these issues by providing a sustainable and scalable alternative to traditional rubber production.

Key Strategic Focus

Core Objectives

• Sustainable Production: Develop and commercialize carbon-negative natural rubber and other industrial ingredients through biotechnological processes.

• Scalability: Establish industrial-scale production capabilities to meet global demand for sustainable materials.

• Innovation Leadership: Position baCta at the forefront of synthetic biology and biomanufacturing innovations.

Areas of Specialization

• Synthetic Biology: Utilizing engineered microorganisms for the production of industrial ingredients.

• Bioprocess Optimization: Enhancing fermentation and downstream processes for efficient scaling.

• AI and Robotics Integration: Employing AI models and robotic systems to accelerate strain development and data collection.

Key Technologies Utilized

• Genome-to-Factory AI Model: An AI-driven approach for predictive throughput and optimized strain development.

• Precision Biofoundry: A proprietary system combining wet-lab automation with AI to expedite high-throughput screening.

• Full-Stack Bioproduction: Standardized bioprocesses for fermentation and downstream processes, enabling efficient scaling.

Primary Markets Targeted

• Automotive Industry: Supplying sustainable rubber for tires and components.

• Footwear Sector: Providing eco-friendly rubber alternatives for shoes.

• Consumer Goods: Offering sustainable materials for various products requiring rubber components.

Financials and Funding

Funding History

In October 2024, baCta secured €3.3 million in pre-seed funding. The round was led by OVNI Capital, with participation from Kima Ventures, Sharpstone Capital, another.vc, and notable business angels such as Thibaud Elziere and Nicolas Morin.

Utilization of Capital

The funds are allocated towards:

• Research and Development: Advancing biotechnological processes and product development.

• Team Expansion: Recruiting scientists and engineers to scale operations.

• Infrastructure Enhancement: Building facilities for industrial-scale production.

Pipeline Development

Key Pipeline Candidates

• Natural Rubber: Currently in the proof-of-concept stage using engineered E. coli strains.

Stages of Development

• Proof of Concept: Demonstrated successful production of natural rubber in laboratory settings.

• Prototype Manufacturing: Collaborating with fashion and industrial companies to produce initial prototypes.

• Pilot Scale Production: Engineering microbial strains for larger-scale production.

Target Conditions

• Natural Rubber: Addressing environmental concerns associated with traditional rubber production.

Anticipated Milestones

• Prototype Completion: Expected within the next 12 months.

• Pilot Production: Initiation planned within 18 months.

Technological Platform and Innovation

Proprietary Technologies

• Synthetic Organelles Platform: Developed at INSERM, this platform enables polymer production within E. coli, mimicking natural rubber synthesis.

Significant Scientific Methods

• Metabolic Engineering: Optimizing microbial pathways for efficient isoprene and rubber production.

• AI-Driven Data Collection: Utilizing AI models to accelerate strain development and process optimization.

AI-Driven Capabilities

• Predictive Modeling: Forecasting optimal production conditions and strain performance.

• Process Automation: Integrating AI with robotic systems for high-throughput screening and data analysis.

Leadership Team

Key Executives

• Mathieu Nohet: Founder and CEO. Previously founded Manty, a data analytics company acquired by Relyens in 2022.

• Marie Rouquette, PhD: Chief Operating Officer. Former Senior Project Manager at Eligo Bioscience.

• Selcuk Aslan: Chief Scientific Officer. Former Team Lead at Neoplants.

Leadership Changes

No significant leadership changes have been reported since the company's inception.

Competitor Profile

Market Insights and Dynamics

The global natural rubber market is valued at approximately $40 billion, with traditional production methods contributing to environmental degradation. Sustainable alternatives are gaining traction as industries seek eco-friendly materials.

Competitor Analysis

• Genencor: Develops engineered bacteria for isoprene production from biomass.

• Synthos: A Polish chemical company manufacturing synthetic rubber.

Strategic Collaborations and Partnerships

baCta has engaged with leading scientists and biotech founders, including Professor Ariel Lindner (INSERM, Université Paris Cité), Professor Pablo Nikel (DTU University), and Dr. Steffen Lindner-Mehlich (Charité – Universitätsmedizin Berlin), to advance its technological platform.

Operational Insights

baCta's integration of AI and synthetic biology positions it uniquely in the market, offering a scalable and sustainable alternative to traditional rubber production methods.

Strategic Opportunities and Future Directions

• Product Diversification: Expanding beyond natural rubber to include other isoprenoids used in pharmaceuticals, agriculture, and biofuels.

• Geographic Expansion: Establishing production facilities in key markets to meet global demand.

• Strategic Partnerships: Collaborating with automotive and consumer goods companies to integrate sustainable materials into their supply chains.

Contact Information

Official Website

Available upon request.

LinkedIn

Available upon request.

Headquarters Location

Paris, France